Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma
- 31 May 1987
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 24 (3) , 231-236
- https://doi.org/10.1007/bf00205635
Abstract
Tumours produce substances that inhibit the expression of cell-mediated immunity, in the form of delayed-type hypersensitivity in mice. Phenol-saline extracts of bovine ocular squamous cell carcinoma (BOSCC) which have immunotherapeutic activity in cattle were able to immunize mice against this depressive effect. Such immunization was effective against products of BOSCC, a spontaneous rat tumour, three of four human tumour cell lines and (in other experiments) mouse tumours. Phenol-saline extracts of mouse tumour cell lines were immunogenic (protective against depression of delayed-type hypersensitivity) in mice. Fractions of BOSCC phenol-saline extracts which were immunotherapeutically active in cattle were generally also protective in mice. The protective activity was lost after treatment with proteinase K, and was present in the supernatant after precipitation with 55% ammonium sulphate. It was not affected by treatment with RNase or DNase or by heating to 50 °C for 2 h. It was present in gel filtration fractions with an apparent molecular weight of 10,000–37,000 daltons. The immunogenic factor in mice and the immunotherapeutic factor in cattle may be related to each other.Keywords
This publication has 25 references indexed in Scilit:
- Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Retroviral Envelope ProteinsScience, 1985
- Suppression of the responsiveness of lymphocytes from cancer patients triggered by co-culture with autologous tumor-derived cells.The Journal of Immunology, 1983
- Bovine Ocular Squamous Cell Carcinoma: Tumor-Associated Immunity Detected by E-Rosette Augmentation Test2JNCI Journal of the National Cancer Institute, 1983
- Characterization of Anti-Inflammatory Factors Produced by Murine Tumor Cells in Culture23JNCI Journal of the National Cancer Institute, 1982
- Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses.Journal of Clinical Investigation, 1981
- Macrophages and Resistance to Tumors. IV. Influence of Age on Susceptibility of Mice to Anti-inflammatory and Antimacrophage Effects of Tumor Cell Products23JNCI Journal of the National Cancer Institute, 1980
- DELAYED-HYPERSENSITIVITY IN MICE INDUCED BY INTRAVENOUS SENSITIZATION WITH SHEEP ERYTHROCYTES - EVIDENCE FOR TUBERCULIN TYPE DELAYED-HYPERSENSITIVITY OF REACTION1978
- MACROPHAGES AND RESISTANCE TO TUMORS .1. INHIBITION OF DELAYED-TYPE HYPERSENSITIVITY REACTIONS BY TUMOR-CELLS AND BY SOLUBLE PRODUCTS AFFECTING MACROPHAGES1978
- Antiinflammatory Effects of Murine Malignant CellsProceedings of the National Academy of Sciences, 1974
- INFLUENCE OF DOSE AND ROUTE OF ANTIGEN INJECTION ON THE IMMUNOLOGICAL INDUCTION OF T CELLSThe Journal of Experimental Medicine, 1974